Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist

Hugh S. Taylor(Yale University), Kristof Chwalisż(AbbVie (United States)), Jan Kotarski(Medical University of Lublin), Nicholas Leyland(McMaster University), W. Rachel Duan(AbbVie (United States)), Linda C. Giudice(University of California, San Francisco), John C. Gallagher(Creighton University), Bruce A. Lessey(Prisma Health), Brittany Schwefel(AbbVie (United States)), J.P. Rowan(AbbVie (United States)), James A. Simon(George Washington University), Juki Ng(AbbVie (United States)), Nelson B. Watts(Mercy Health), James W. Thomas(AbbVie (United States)), Bruce R. Carr(Baylor College of Medicine), David F. Archer(Eastern Virginia Medical School), Neil P. Johnson(St John New Zealand), Eric S. Surrey(Colorado Center for Reproductive Medicine), Rita I. Jain(AbbVie (United States)), Maurício Simões Abrão(Universidade de São Paulo), W. Paul Dmowski(Creighton University), Michael P. Diamond(Wayne State University)
New England Journal of Medicine
May 19, 2017
Cited by 492


Related Papers